跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
SANDOZ GEFITINIB
Authorized
STANDARD
SANDOZ GEFITINIB
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cd5a8eff99d7927c
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
cd5a8eff99d7927c
Drug Approval Canada Name
SANDOZ GEFITINIB
Product Name
SANDOZ GEFITINIB
Status
Marketed
Status Date
2019-06-26
Original Market Date
2019-06-26
Din
02487748
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01EB01 GEFITINIB
Atc Name
l 01 eb 01
Aig Number
0149783001
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
GEFITINIB
250 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cd5a8eff99d7927c
Type
Standard
Back to Health Canada Approvals
SANDOZ GEFITINIB - Health Canada Drug Approval Details